Find a Clinical Trial

Showing 1 - 3 out of 3

AN2 EBO301 MAC Study

A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter, Prospective Study to Assess the Efficacy, Safety, and Pharmacokinetics of Orally Administered Epetraborole in Patients with Treatment-refractory Mycobacterium avium Complex Lung Disease (MACrO2)

Mycobacterial disease

All genders

18+

Recruiting now

Department of Medicine, Division of Geographic Medicine + Infectious Diseases

Tufts Medical Center

Learn more

SMART Trial

SMall Annuli Randomized To Evolut^™ Trial (SMART Trial)

Aortic stenosis

All genders

No minimum age

Recruiting now

CardioVascular Center

Tufts Medical Center

Learn more

Automated Screening for Aortic Stenosis

Validation of System for Automated Screening for Aortic Stenosis

Aortic stenosis, Structural heart disease

All genders

18+

Recruiting now

CardioVascular Center

Tufts Medical Center

Learn more

Find Care

Services + Treatments

Patients + Visitors

Research + Academics

Clinicians

Find a Clinical Trial

Filter

A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter, Prospective Study to Assess the Efficacy, Safety, and Pharmacokinetics of Orally Administered Epetraborole in Patients with Treatment-refractory Mycobacterium avium Complex Lung Disease (MACrO2)

SMall Annuli Randomized To Evolut^™ Trial (SMART Trial)

Validation of System for Automated Screening for Aortic Stenosis

Find Care

Services + Treatments

Patients + Visitors

Research + Academics

Clinicians

Find a Clinical Trial

Filter

A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter, Prospective Study to Assess the Efficacy, Safety, and Pharmacokinetics of Orally Administered Epetraborole in Patients with Treatment-refractory Mycobacterium avium Complex Lung Disease (MACrO2)

SMall Annuli Randomized To Evolut™ Trial (SMART Trial)

Validation of System for Automated Screening for Aortic Stenosis

SMall Annuli Randomized To Evolut^™ Trial (SMART Trial)